214 related articles for article (PubMed ID: 2855603)
1. Comparison of three recombinant murine leukemia viruses carrying the v-src oncogene of avian sarcoma virus: differences in in vitro transformation and in vivo pathogenicity.
Feuerman MH; Lee WT; Pattengale PK; Fan H
Mol Carcinog; 1988; 1(1):57-66. PubMed ID: 2855603
[TBL] [Abstract][Full Text] [Related]
2. Generation of a recombinant Moloney murine leukemia virus carrying the v-src gene of avian sarcoma virus: transformation in vitro and pathogenesis in vivo.
Feuerman MH; Davis BR; Pattengale PK; Fan H
J Virol; 1985 Jun; 54(3):804-16. PubMed ID: 2987532
[TBL] [Abstract][Full Text] [Related]
3. Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus.
Anderson SM; Scolnick EM
J Virol; 1983 May; 46(2):594-605. PubMed ID: 6302322
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a murine retrovirus with a temperature-sensitive src gene.
Anderson SM; Rands E; Fincham VJ; Wyke JA
Virology; 1987 Sep; 160(1):263-7. PubMed ID: 2820134
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis.
Brightman BK; Pattengale PK; Fan H
J Virol; 1986 Oct; 60(1):68-81. PubMed ID: 3018301
[TBL] [Abstract][Full Text] [Related]
6. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses.
DesGroseillers L; Jolicoeur P
J Virol; 1984 Nov; 52(2):448-56. PubMed ID: 6092670
[TBL] [Abstract][Full Text] [Related]
7. A murine recombinant retrovirus containing the src oncogene transforms erythroid precursor cells in vitro.
Anderson SM; Klinken SP; Hankins WD
Mol Cell Biol; 1985 Dec; 5(12):3369-75. PubMed ID: 3939314
[TBL] [Abstract][Full Text] [Related]
8. Transduction of the cellular src gene and 3' adjacent sequences in avian sarcoma virus PR2257.
Geryk J; Dezélée P; Barnier JV; Svoboda J; Nehyba J; Karakoz I; Rynditch AV; Yatsula BA; Calothy G
J Virol; 1989 Feb; 63(2):481-92. PubMed ID: 2463376
[TBL] [Abstract][Full Text] [Related]
9. Correlation of V-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line.
Gilmer TM; Lamb PW; Oshimura M; Barrett JC
Cancer Res; 1987 Sep; 47(17):4663-6. PubMed ID: 3040229
[TBL] [Abstract][Full Text] [Related]
10. Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements.
Even J; Anderson SJ; Hampe A; Galibert F; Lowy D; Khoury G; Sherr CJ
J Virol; 1983 Mar; 45(3):1004-16. PubMed ID: 6300443
[TBL] [Abstract][Full Text] [Related]
11. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
12. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
Verderame MF; Kaplan JM; Varmus HE
J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
[TBL] [Abstract][Full Text] [Related]
13. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
14. v-src mutations outside the carboxyl-coding region are not sufficient to fully activate transformation by pp60c-src in NIH 3T3 cells.
Reddy S; Yaciuk P; Kmiecik TE; Coussens PM; Shalloway D
Mol Cell Biol; 1988 Feb; 8(2):704-12. PubMed ID: 2451122
[TBL] [Abstract][Full Text] [Related]
15. Retroviral src gene expression in continuous marrow culture increases the self-renewal capacity of multilineage hematopoietic stem cells.
Ohta M; Anklesaria P; Wheaton M; Ohara A; Pierce JH; Holland CA; Greenberger JS
Leukemia; 1989 Mar; 3(3):206-26. PubMed ID: 2918758
[TBL] [Abstract][Full Text] [Related]
16. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
Jong SM; Zong CS; Dorai T; Wang LH
J Virol; 1992 Aug; 66(8):4909-18. PubMed ID: 1321277
[TBL] [Abstract][Full Text] [Related]
17. Localization of temperature-sensitive transformation mutations and back mutations in the Rous sarcoma virus src gene.
Fincham VJ; Wyke JA
J Virol; 1986 May; 58(2):694-9. PubMed ID: 3009882
[TBL] [Abstract][Full Text] [Related]
18. BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.
Clark SS; Chen E; Fizzotti M; Witte ON; Malkovska V
J Virol; 1993 Oct; 67(10):6033-46. PubMed ID: 8396667
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic transformation of normal and carcinogen-induced preneoplastic Syrian hamster embryo cells by the v-src oncogene.
Gilmer TM; Annab LA; Oshimura M; Barrett JC
Mol Cell Biol; 1985 Jul; 5(7):1707-13. PubMed ID: 2991747
[TBL] [Abstract][Full Text] [Related]
20. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
Fan H; Chute H; Chao E; Pattengale PK
Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
